| cryo EM structure of apo hMRP4 | | monomer | 1-1298 | 100.0 | |
|
| cryo-EM structure of ATP-bound hMRP4 | | monomer | 6-1301 | 99.76 | 2×ATP; 2×MG; |
|
| cryo-EM structure of sulindac-bound hMRP4 | | monomer | 5-1299 | 100.0 | 1×SUZ; |
|
| cryo-EM structure of PGE1-bound hMRP4 | | monomer | 7-1298 | 100.0 | 1×XPG; |
|
| Cryo-EM structure of ATP-U46619-bound ABCC4 | | monomer | 9-1298 | 99.92 | 2×ATP; 2×MG; 1×PUC; |
|
| Cryo-EM structure of apo-form ABCC4 | | monomer | 9-1298 | 100.0 | |
|
| Cryo-EM structure of aspirin-bound ABCC4 | | monomer | 9-1298 | 100.0 | 1×AIN; |
|
| Cryo-EM structure of U46619-bound ABCC4 | | monomer | 9-1298 | 100.0 | 1×PUC; |
|
| Cryo-EM structure of dipyridamole-bound ABCC4 | | monomer | 9-1298 | 100.0 | 1×H9F; |
|
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (inward-facing conformation) | | monomer | 7-1294 | 100.0 | 2×CLR; 4×Y01; |
|
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with methotrexate) | | monomer | 7-1294 | 100.0 | 1×MTX; |
|
| Cryo-EM structure of nanodisc-reconstituted human MRP4 with E1202Q mutation (outward-facing occlude… | | monomer | 7-1294 | 99.92 | 2×ATP; 2×MG; |
|
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with topotecan) | | monomer | 7-1294 | 100.0 | 1×TTC; |
|
| Cryo-EM structure of nanodisc-reconstituted wildtype human MRP4 (in complex with prostaglandin E2) | | monomer | 7-1294 | 100.0 | 1×P2E; |
|
| Cryo-EM structure of human ABCC4 | | monomer | 6-1280 | 100.0 | 14×DU0; 1×PLM; |
|
| Cryo-EM structure of human ABCC4 in complex with ANP-bound in NBD1 and METHOTREXATE | | monomer | 7-1277 | 100.0 | 1×ANP; 1×MTX; 14×DU0; 1×PLM; 1×MG; |
|
| Cryo-EM structure of human ABCC4 with ANP bound in NBD1 | | monomer | 7-1277 | 100.0 | 1×ANP; 8×DU0; 1×PLM; 1×MG; |
|